Clinical trial
An Safety and Efficacy Study of Abiraterone Acetate in Participants With…
NCT00474383 · Cougar Biotechnology, Inc., Industry · Completed
Key facts
| NCT number | NCT00474383 |
|---|---|
| Title | An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy |
| Official title | A Phase II Open Label Study of CB7630 (Abiraterone Acetate) in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy |
| Lead sponsor | Cougar Biotechnology, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Neoplasms |
| Intervention type | Drug |
| Interventions | Abiraterone acetate, Glucocorticoid |
| Enrollment | 47 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | May 16, 2007 |
| Last update posted | May 12, 2014 |
| Countries | United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: